APT Medical Inc Net Assets
APT Medical Inc net assets. Based on the latest financial reports, APT Medical Inc (688617) has net assets worth CN¥3.01 Billion CNY (≈ $440.03 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.43 Billion ≈ $501.99 Million USD) and total liabilities (CN¥423.40 Million ≈ $61.96 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset momentum of APT Medical Inc to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥3.01 Billion |
| % of Total Assets | 87.66% |
| Annual Growth Rate | 40.07% |
| 5-Year Change | 77.43% |
| 10-Year Change | N/A |
| Growth Volatility | 92.09 |
Net Assets of APT Medical Inc (2017–2025)
Net assets of APT Medical Inc from 2017 to 2025. This chart illustrates how APT Medical Inc's net assets have evolved over time, based on quarterly financial data. See APT Medical Inc (688617) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Net Assets for APT Medical Inc (2017–2025)
The table below shows the annual net assets of APT Medical Inc from 2017 to 2025. For live market cap and overall valuation, see 688617 market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥3.18 Billion ≈ $465.03 Million |
+24.39% |
| 2024-12-31 | CN¥2.55 Billion ≈ $373.85 Million |
+30.22% |
| 2023-12-31 | CN¥1.96 Billion ≈ $287.10 Million |
+9.54% |
| 2022-12-31 | CN¥1.79 Billion ≈ $262.09 Million |
+0.00% |
| 2021-12-31 | CN¥1.79 Billion ≈ $262.09 Million |
+297.94% |
| 2020-12-31 | CN¥450.09 Million ≈ $65.86 Million |
+30.12% |
| 2019-12-31 | CN¥345.90 Million ≈ $50.62 Million |
+27.78% |
| 2018-12-31 | CN¥270.70 Million ≈ $39.61 Million |
+26.24% |
| 2017-12-31 | CN¥214.43 Million ≈ $31.38 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to APT Medical Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2191.4% over the analyzed period, indicating profitable operations and earnings retention.
APT Medical Inc Net Assets Breakdown (December 2025)
APT Medical Inc net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥2.29 Billion | 74.16% |
| Common Stock | CN¥141.03 Million | 4.57% |
| Other Comprehensive Income | CN¥79.46 Million | 2.57% |
| Other Components | CN¥577.77 Million | 18.71% |
| Total Equity | CN¥3.09 Billion | 100.00% |
APT Medical Inc Competitors by Market Cap
The table below lists competitors of APT Medical Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ZALANDO SE UNSP.ADR /2
F:ZAL1
|
$5.91 Billion |
|
Hebei Yangyuan ZhiHui Beverage Co Ltd
SHG:603156
|
$5.91 Billion |
|
Kuang Chi Technologies Co Ltd
SHE:002625
|
$5.92 Billion |
|
Giant Network Group Co Ltd
SHE:002558
|
$5.92 Billion |
|
Carlsberg A/S
CO:CARL-A
|
$5.91 Billion |
|
SHISEIDO CO. ADR
F:SHDA
|
$5.90 Billion |
|
Shan Dong Sun Paper Industry Joint Stock Co Ltd
SHE:002078
|
$5.90 Billion |
|
Perseus Mining Ltd
AU:PRU
|
$5.90 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in APT Medical Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,516,339,545 to 3,088,667,057, a change of 572,327,512 (22.7%).
- Net income of 820,636,583 contributed positively to equity growth.
- Dividend payments of 170,189,064 reduced retained earnings.
- Share repurchases of 99,942,513 reduced equity.
- Other comprehensive income decreased equity by 8,102,447.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥820.64 Million | +26.57% |
| Dividends Paid | CN¥170.19 Million | -5.51% |
| Share Repurchases | CN¥99.94 Million | -3.24% |
| Other Comprehensive Income | CN¥-8.10 Million | -0.26% |
| Other Changes | CN¥29.92 Million | +0.97% |
| Total Change | CN¥- | 22.74% |
Book Value vs Market Value Analysis
This analysis compares APT Medical Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 13.02x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 140.01x to 13.02x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | CN¥2.04 | CN¥285.26 | x |
| 2018-12-31 | CN¥2.57 | CN¥285.26 | x |
| 2019-12-31 | CN¥3.32 | CN¥285.26 | x |
| 2020-12-31 | CN¥4.39 | CN¥285.26 | x |
| 2021-12-31 | CN¥12.89 | CN¥285.26 | x |
| 2022-12-31 | CN¥12.42 | CN¥285.26 | x |
| 2023-12-31 | CN¥13.45 | CN¥285.26 | x |
| 2024-12-31 | CN¥17.84 | CN¥285.26 | x |
| 2025-12-31 | CN¥21.90 | CN¥285.26 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently APT Medical Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 26.57%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 31.76%
- • Asset Turnover: 0.71x
- • Equity Multiplier: 1.18x
- Recent ROE (26.57%) is above the historical average (20.56%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 16.10% | 22.51% | 0.61x | 1.18x | CN¥13.06 Million |
| 2018 | 7.97% | 8.90% | 0.74x | 1.21x | CN¥-5.47 Million |
| 2019 | 23.62% | 20.44% | 0.72x | 1.60x | CN¥47.62 Million |
| 2020 | 24.06% | 23.11% | 0.81x | 1.28x | CN¥64.74 Million |
| 2021 | 11.69% | 25.09% | 0.41x | 1.13x | CN¥30.11 Million |
| 2022 | 20.30% | 29.44% | 0.55x | 1.26x | CN¥181.69 Million |
| 2023 | 28.00% | 32.35% | 0.64x | 1.35x | CN¥343.21 Million |
| 2024 | 26.75% | 32.59% | 0.69x | 1.18x | CN¥421.52 Million |
| 2025 | 26.57% | 31.76% | 0.71x | 1.18x | CN¥511.77 Million |
Industry Comparison
This section compares APT Medical Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,430,187,814
- Average return on equity (ROE) among peers: 15.02%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| APT Medical Inc (688617) | CN¥3.01 Billion | 16.10% | 0.14x | $5.91 Billion |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $4.98 Billion | -4.70% | 0.37x | $384.61 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $154.18 Million | 20.46% | 1.55x | $4.24 Billion |
| Double Medical Technology Inc (002901) | $2.59 Billion | 26.01% | 0.31x | $2.56 Billion |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $6.77 Billion | 62.15% | 0.36x | $494.04 Million |
| Lepu Medical Tech Beijing (300003) | $3.29 Billion | 12.85% | 0.16x | $3.40 Billion |
| INKON Life Technology Co Ltd (300143) | $74.89 Million | 13.27% | 0.87x | $817.03 Million |
| Edan Instruments Inc (300206) | $1.18 Billion | 2.94% | 0.08x | $1.02 Billion |
| Guangdong Biolight Meditech Co Ltd (300246) | $393.88 Million | 7.34% | 0.20x | $505.98 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.72 Billion | -4.37% | 0.06x | $473.66 Million |
| Sinocare Inc (300298) | $3.14 Billion | 14.20% | 0.47x | $1.56 Billion |
About APT Medical Inc
APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagno… Read more